Tezspire nearly eliminated the need for surgery, reducing surgical intervention by 98 per cent
Includes new $1.2 billion investment in manufacturing facilities, AI and advanced digital technologies, creating hundreds of highly skilled U.S. jobs
Accelerating RNA-based therapeutic solutions for customers through co-development of products and formulation support
Pfizer's vaccine helps protect against clinically relevant 20 serotypes responsible for a majority of invasive and non-invasive pneumococcal disease
his is the second license extension of a Nurix autoimmune disease program by Sanofi in the last 90 days
Lupin is set to become first Indian company to fully integrate Honeywell’s Solstice® Air in its respiratory inhalers at scale, redefining respiratory care with near-zero global warming potential propellants
Vote expands existing recommendation, which was for all adults aged 75 and older and high-risk adults aged 60 to 74
Dupixent (dupilumab) approved as the first-ever biologic medicine in Japan for patients with Chronic Obstructive Pulmonary Disease (COPD)
Around 100 million people live with COPD in China, accounting for almost 25% of all COPD cases globally
The transaction is expected to result in approximately $175 million to support further development of IMG-007
Subscribe To Our Newsletter & Stay Updated
